CLINICAL_TRIALS
trial_result
· 2013-12-24
Clinical Trial Update: Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema [Phase 3]
Summary
Phase 3 trial update evaluating subcutaneous icatibant for acute attacks of hereditary angioedema has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Angioedema | Phase 3 | Status: COMPLETED | Results posted: 2013-12-24